New
Viralgen
Viralgen Vector Core is a leading Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) specialising in the production of recombinant adeno-associated virus (rAAV) viral vectors.
Description
Viralgen is a global leader in the development and manufacturing of recombinant adeno-associated virus (rAAV) gene therapies. As an independent CDMO and a subsidiary of AskBio, Viralgen provides cGMP rAAV manufacturing services to accelerate gene therapy advancements for genetic diseases.
Based in San Sebastián, Spain, Viralgen is committed to offering innovative solutions in gene therapy, using its proprietary platforms to support clients at every stage, from clinical production to commercial scale. The company is renowned for its robust scientific expertise and industry-leading facilities, dedicated solely to AAV production.
Key Products and Services
- AAV gene therapy vector production
- Suspension, triple transfection platform
- Pro10™ HEK293 cell line
- Full range of services from construct optimisation to commercial production
- Regulatory support for CMC filings
- Fill and finish across multiple formats
Viralgen’s focus on cutting-edge technology and commitment to scalability positions it as a trusted partner for advancing life-changing therapies. Through its expertise and infrastructure, the company continues to support the global gene therapy community in its mission to deliver transformative medicines.
Certification
Europe EMA, Spain AEMPS
Capabilities
Contact Information
Website
Phone
Twitter (X)
Address
170 Paseo de Miramón, 3ª planta, San Sebastián, País Vasco, 20014, Spain
Zip/Post Code
20014
Stay ahead of trends and best practices 
Exclusive downloads and podcasts 
Get invites to special events and meetups 
